The endocannabinoid system: From biology to therapy

Pharmacological Research

Volumn 60, Issue 2, 2009, Pages 75-76

  Bifulco, Prof Maurizio ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DOXORUBICIN; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUCOSE; LIPID;

ANGIOGENESIS; ANOREXIA; APOPTOSIS; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BODY WEIGHT; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COGNITIVE DEFECT; COLON CANCER; DIABETES MELLITUS; DRUG ABUSE; DRUG PENETRATION; DRUG TARGETING; DYSLIPIDEMIA; EDITORIAL; EMOTIONAL DISORDER; ENERGY BALANCE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEMORRHAGIC SHOCK; HUMAN; HYPERTENSION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INHIBITION KINETICS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; METASTASIS INHIBITION; NAUSEA; PAIN; PRIORITY JOURNAL; SIDE EFFECT; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ANIMALS; BIOLOGY; ENDOCANNABINOIDS; HUMANS; RECEPTOR, CANNABINOID, CB1;

EID: 67449113528     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.04.015     Document Type: Editorial

References (13)

1. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 (2006) 389-462
2. Drago F. Endocannabinoids and psychopathology: the therapy inside. Pharmacol Res 56 (2007) 357-359
3. Di Marzo V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60 (2009) 77-84
4. Pandey R., Mousawy K., Nagarkatti M., and Nagarkatti P. Endocannabinoids and immune regulation. Pharmacol Res 60 (2009) 85-92
5. Nogueiras R., Diaz-Arteaga A., Lockie S., Velasquez D.A., Tschöp J., López M., et al. The endocannabioid system: role in glucose and energy metabolism. Pharmacol Res 60 (2009) 93-98
6. Pacher P., Mukhopadhyay P., Mohanraj R., Godlewski G., Bátkai S., and Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension 52 (2008) 601-607
7. Bátkai P., and Pacher P. Endocannabinoids and cardiac contractile function: pathophysiological implications. Pharmacol Res 60 (2009) 99-106
8. Pisanti S., Malfitano A.M., Grimaldi C., Santoro A., Gazzerro P., Laezza C., et al. Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Best Pract Res Clin Endocrinol Metab 23 (2009) 117-131
9. Pisanti S., and Bifulco M. Endocannabinoid system modulation in cancer biology and therapy. Pharmacol Res 60 (2009) 107-116
10. Izzo A., and Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res 60 (2009) 117-125
11. Lewis S.E., and Maccarrone M. Endocannabinoids, sperm biology and human fertility. Pharmacol Res 60 (2009) 126-131
12. Realini N., Rubino T., and Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res 60 (2009) 132-138
13. Bifulco M., Grimaldi C., Gazzerro P., Pisanti S., and Santoro A. Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. Mol Pharmacol 71 (2007) 1445-1456